JD Supra3d
FDA Publishes Its First Draft Guidance On Use of Artificial Intelligence in the Development of Drugs and Biological Products
On January 7, 2025, the FDA issued a draft guidance called Considerations for the Use of Artificial Intelligence to Support Regulatory ...
JD Supra12d
Drugs and Biologics at FDA: Reflections on 2024 Activity Shed Light on the Road Ahead
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...
MedPage Today17d
HHS Inspector General Raises Concerns Over FDA's Accelerated Approvals
In light of this, the OIG examined the FDA's decision-making process in a sample of ... program was designed to speed the development and review of new drugs to treat serious and life-threatening ...
The Conversation29d
Will AI revolutionize drug development? Researchers explain why it depends on how it’s used
Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries ... AI and machine learning to every stage of the drug development process. This includes identifying targets in the ...